It is noteworthy that the 17p13 region harbors the tumor suppressor gene TP53, and the biallelic inactivation of the TP53 gene has been proposed as a distinct subtype in adult patients (MDS-biTP53), given that it leads to loss of function and poor prognosis [1,4,42]. This evidence concerns the gene TP53 and myelodysplastic syndrome.